Diese Übersetzung wird noch vorbereitet. Bis dahin zeigen wir vorübergehend die englische Originalversion.
Geschäft · 10.7.19971 Min. Lesezeit
Kensey Nash Corp.; Premarket Approval of the Angio- SealSUPTM/SUP Hemostatic Puncture Closure Device
Lokale automatische Übersetzung · Originalsprache der Quelle
Zusammenfassung
The Food and Drug Administration (FDA) is announcing its approval of the application by Kensey Nash Corp., Exton, PA, for premarket approval, under the Federal Food, Drug, and Cosmetic Act (the act), of the Angio-Seal TM Hemostatic Puncture Closure Device. After reviewing the recommendation of the Circulatory System Devices Panel, FDA's Center for Devices and Radiological Health (CDRH) notified the applicant, by letter of September 30, 1996, of the approval of the application.
Originalsprache der Quelle: Federal Register — Food and Drug AdministrationOriginalquelle öffnen →